In vitro, antigen-specific CTLs generated against HLA-A*02:01 and HLA-A*24:02-restricted SLC45A2 peptides were shown to kill most HLA-matched melanoma cells lines, including uveal melanoma cells. This evidence concerns the gene HLA-A and melanoma.